Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Characterizing the role of Mediator subunit 15 in pancreatic alpha cells

EF 2020-21

Résumé
Diabetes is a chronic disease in which the body is unable to regulate the amount of sugar in the blood. Currently, ten percent of Canadians live with diabetes and this percentage is expected to increase to 12% over the next decade. Blood sugar must be tightly regulated to ensure the body functions properly. High blood sugar levels can lead to diabetes-related complications by damaging organs, blood vessels, and nerves. Hormones produced by the pancreas regulate blood sugar levels and their function is impaired in diabetes. Glucagon is an example of such hormones and it recruits sugar from the liver when blood sugar levels are too low. However, glucagon production is dysregulated in diabetes and can be produced even when blood sugar levels are high, further increasing blood sugar levels in these individuals and potentiating diabetes-related complications. The mechanism underlying glucagon production and its disruption in diabetes remains unclear. Previous data generated from our lab show that mice missing Mediator in early pancreatic cells produce less glucagon-producing cells. Interestingly, the data also suggest Mediator interacts with genes important for glucagon function. We will test whether mice missing Mediator in glucagon-producing cells can maintain glucagon function. We will also examine possible Mediator-dependent mechanisms underlying this hormone regulation. We predict this investigation will identify new mechanisms that regulate glucagon production. These insights will help reveal mechanisms that may be disrupted in diabetes patients with aberrant glucagon secretion; and subsequently, they will help generate potential therapies to treat these patients.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
449323
Name
Mar Samantha
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Characterizing the role of Mediator subunit 15 in pancreatic alpha cells
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Alpha Cells; Development; Diabetes; Endocrine Progenitors; Gene Regulation; Genetic Knockout; Glucagon; Mediator Subunit 15; Mouse Models; Transcription Coregulators
Abstract
Diabetes is a chronic disease in which the body is unable to regulate the amount of sugar in the blood. Currently, ten percent of Canadians live with diabetes and this percentage is expected to increase to 12% over the next decade. Blood sugar must be tightly regulated to ensure the body functions properly. High blood sugar levels can lead to diabetes-related complications by damaging organs, blood vessels, and nerves. Hormones produced by the pancreas regulate blood sugar levels and their function is impaired in diabetes. Glucagon is an example of such hormones and it recruits sugar from the liver when blood sugar levels are too low. However, glucagon production is dysregulated in diabetes and can be produced even when blood sugar levels are high, further increasing blood sugar levels in these individuals and potentiating diabetes-related complications. The mechanism underlying glucagon production and its disruption in diabetes remains unclear. Previous data generated from our lab show that mice missing Mediator in early pancreatic cells produce less glucagon-producing cells. Interestingly, the data also suggest Mediator interacts with genes important for glucagon function. We will test whether mice missing Mediator in glucagon-producing cells can maintain glucagon function. We will also examine possible Mediator-dependent mechanisms underlying this hormone regulation. We predict this investigation will identify new mechanisms that regulate glucagon production. These insights will help reveal mechanisms that may be disrupted in diabetes patients with aberrant glucagon secretion; and subsequently, they will help generate potential therapies to treat these patients.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Mar, Samantha
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~